Daily Papers

MEGA is a recent transformer-based architecture, which utilizes a linear recurrent operator whose parallel computation, based on the FFT, scales as O(LlogL), with L being the sequence length. We build upon their approach by replacing the linear recurrence with a special temporal convolutional network which permits larger receptive field size with shallower networks, and reduces the computational complexity to O(L). The resulting model is called TCNCA, a Temporal Convolutional Network with Chunked Attention. We evaluate TCNCA on EnWik8 language modeling, long-range-arena (LRA) sequence classification, as well as a synthetic reasoning benchmark associative recall. On EnWik8, TCNCA outperforms MEGA, reaching a lower loss with 1.37times/1.24times faster forward/backward pass during training. The dilated convolutions used in TCNCA are consistently and significantly faster operations than the FFT-based parallelized recurrence in GPUs, making them a scalable candidate for handling very large sequence lengths: they are up to 7.07times/2.86times faster in the forward/backward pass for sequences up to 131k. Further on LRA, TCNCA achieves, on average, 1.28times speed-up during inference with similar accuracy to what MEGA achieves. On associative recall, we find that even a simplified version of TCNCA, without excessive multiplicative and additive interactions, remains superior or competitive to MEGA on a range of sequence lengths and vocabulary sizes.

Pathology diagnosis based on EEG signals and decoding brain activity holds immense importance in understanding neurological disorders. With the advancement of artificial intelligence methods and machine learning techniques, the potential for accurate data-driven diagnoses and effective treatments has grown significantly. However, applying machine learning algorithms to real-world datasets presents diverse challenges at multiple levels. The scarcity of labelled data, especially in low regime scenarios with limited availability of real patient cohorts due to high costs of recruitment, underscores the vital deployment of scaling and transfer learning techniques. In this study, we explore a real-world pathology classification task to highlight the effectiveness of data and model scaling and cross-dataset knowledge transfer. As such, we observe varying performance improvements through data scaling, indicating the need for careful evaluation and labelling. Additionally, we identify the challenges of possible negative transfer and emphasize the significance of some key components to overcome distribution shifts and potential spurious correlations and achieve positive transfer. We see improvement in the performance of the target model on the target (NMT) datasets by using the knowledge from the source dataset (TUAB) when a low amount of labelled data was available. Our findings indicate a small and generic model (e.g. ShallowNet) performs well on a single dataset, however, a larger model (e.g. TCN) performs better on transfer and learning from a larger and diverse dataset.